Cancer: looking outside the genome

The ‘gene-centric’ approach has produced a wealth of information about the origins and progression of cancer, and investigators seek a full compilation of altered gene expressions for tumour characterization and treatment. However, the cancer genome appears to be far more unstable than previously thought. It may therefore be prudent to augment gene-level approaches with supra-genomic strategies that circumvent the genomic variability of cancer cells.

[1]  M. Detmar,et al.  Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  V. Weaver,et al.  Tissue structure, nuclear organization, and gene expression in normal and malignant breast. , 1999, Cancer research.

[3]  K. Kinzler,et al.  Genes expressed in human tumor endothelium. , 2000, Science.

[4]  L. Hayflick.  How and why we age , 1994, Experimental Gerontology.

[5]  N. Petrelli,et al.  The onset and extent of genomic instability in sporadic colorectal tumor progression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[6]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[7]  A. Carrel,et al.  AGE AND MULTIPLICATION OF FIBROBLASTS , 1921, The Journal of experimental medicine.

[8]  R H Hruban,et al.  Gene expression profiles in normal and cancer cells. , 1997, Science.

[9]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[10]  L. Sachs.  The control of growth and differentiation in normal and leukemic blood cells , 1990, Cancer.

[11]  J. Folkman,et al.  Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors. , 2000, Cancer research.

[12]  L. Hayflick,et al.  The serial cultivation of human diploid cell strains. , 1961, Experimental cell research.

[13]  J. Shay,et al.  Telomerase in cancer: diagnostic, prognostic, and therapeutic implications. , 1998, The cancer journal from Scientific American.

[14]  David Waddington,et al.  Analysis of telomere lengths in cloned sheep , 1999, Nature.

[15]  J. Folkman.  Editorial: Is Tissue Mass Regulated by Vascular Endothelial Cells? Prostate as the First Evidence. , 1998, Endocrinology.

[16]  H. Rubin.  Telomerase and cellular lifespan: Ending the debate? , 1998, Nature Biotechnology.

[17]  J. Folkman,et al.  Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. , 2000, Cancer research.

[18]  S. Baruchel,et al.  Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. , 2000, The Journal of clinical investigation.

[19]  G. Morin.  The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats , 1989, Cell.

[20]  J. Fortner,et al.  Accomplishments in cancer research , 1991 .

[21]  P. Lansdorp,et al.  Extension of cell life-span and telomere length in animals cloned from senescent somatic cells. , 2000, Science.

[22]  et al.,et al.  The RNA component of human telomerase , 1995, Science.

[23]  L. Hayflick,et al.  Preparation of poliovirus vaccines in a human fetal diploid cell strain. , 1962, American journal of hygiene.

[24]  H. Cooke,et al.  Variability at the telomeres of the human X/Y pseudoautosomal region. , 1986, Cold Spring Harbor symposia on quantitative biology.

[25]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[26]  B. Mcclintock,et al.  The Stability of Broken Ends of Chromosomes in Zea Mays. , 1941, Genetics.

[27]  Donald E. Ingber,et al.  The structural and mechanical complexity of cell-growth control , 1999, Nature Cell Biology.

[28]  T. Hsu,et al.  Choice of a Cell System for Vaccine Production , 1963, Science.

[29]  A. Feinstein.  The Santayana Syndrome II: Problems in Reasoning and Learning About Error , 2015 .

[30]  J. Shay,et al.  The use of telomerized cells for tissue engineering , 2000, Nature Biotechnology.

[31]  R. Chanock,et al.  Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO. , 1962, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Kerbel,et al.  Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti‐cancer therapeutic agents , 1991, BioEssays : news and reviews in molecular, cellular and developmental biology.

[33]  E. Blackburn,et al.  A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. , 1978, Journal of molecular biology.

[34]  M. L. Le Beau,et al.  A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Thomas Boehm,et al.  Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance , 1997, Nature.

[36]  L. Hayflick.  THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.

[37]  Robin C. Allshire,et al.  Telomere reduction in human colorectal carcinoma and with ageing , 1990, Nature.

[38]  J. Watson.  Origin of concatemeric T7 DNA. , 1972, Nature: New biology.

[39]  P. Steeg,et al.  Cancer prognostics: Past, present and p27 , 1997, Nature Medicine.

[40]  A M Olovnikov,et al.  A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. , 1973, Journal of theoretical biology.

[41]  P. Nurse,et al.  Reductionism: The ends of understanding , 1997, Nature.

[42]  P. Hahnfeldt,et al.  Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. , 1999, Cancer research.

[43]  L. S. Cram,et al.  A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Bert Vogelstein,et al.  Genetic instability and darwinian selection in tumours , 1999 .

[45]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[46]  J. Witkowski.  Dr. Carrel's immortal cells. , 1980, Medical History.

[47]  Leonard Hayflick,et al.  The Coming of Age of WI-381 2 , 1984 .

[48]  Alexey M. Olovnikov,et al.  Telomeres, telomerase, and aging: Origin of the theory , 1996, Experimental Gerontology.

[49]  A. Gazdar,et al.  Telomerase in the early detection of cancer. , 1997, Journal of clinical pathology.

[50]  J. Herman,et al.  DNA hypermethylation in tumorigenesis: epigenetics joins genetics. , 2000, Trends in genetics : TIG.

[51]  J. Shay,et al.  Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology , 2000, Nature Medicine.

[52]  K Howard,et al.  The bioinformatics gold rush. , 2000, Scientific American.

[53]  L. Hayflick.  The biology of human aging. , 1981, Plastic and reconstructive surgery.

[54]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[55]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[56]  A. Olovnikov.  [Principle of marginotomy in template synthesis of polynucleotides]. , 1971, Doklady Akademii nauk SSSR.

[57]  G. Bratthauer,et al.  Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. , 2000, Cancer research.

[58]  L. Hayflick,et al.  Nuclear control of cellular aging demonstrated by hybridization of anucleate and whole cultured normal human fibroblasts. , 1975, Experimental cell research.

[59]  L. Hayflick.  [A brief overview of the discovery of cell mortality and immortality and of its influence on concepts about aging and cancer]. , 1999, Pathologie et biologie.

[60]  J. Witkowski.  The myth of cell immortality , 1985 .

[61]  L. Hayflick.  Tissue cultures and mycoplasmas. , 1965, Texas reports on biology and medicine.

[62]  S. Sallan,et al.  Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. , 1997, The American journal of pathology.

[63]  R. Myers,et al.  Structure and variability of human chromosome ends , 1990, Molecular and cellular biology.

[64]  J. Folkman.  Editorial: Is Tissue Mass Regulated by Vascular Endothelial Cells? Prostate as the First Evidence. , 1998, Endocrinology.

[65]  L. Loeb.  Many mutations in cancers. , 1996, Cancer surveys.

[66]  H. Cooke,et al.  In vivo loss of telomeric repeats with age in humans. , 1991, Mutation research.

[67]  Z. Szallasi.  Gene expression patterns and cancer , 1998, Nature Biotechnology.

[68]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Richard C. Strohman,et al.  The coming Kuhnian revolution in biology , 1997, Nature Biotechnology.